Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Angion Biomedica Corp (NQ: ANGN )

1.000 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.000
Bid (Size) 0.8900 (1)
Ask (Size) 1.090 (10)
Prev. Close 1.000
Today's Range 1.000 - 1.000
52wk Range 0.4600 - 2.040
Shares Outstanding 29,798,399
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
From Angion Biomedica Corp.
Via GlobeNewswire
Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool. 
Via Benzinga

Performance

YTD
+14.69%
+14.69%
1 Month
+47.54%
+47.54%
3 Month
+50.24%
+50.24%
6 Month
+8.70%
+8.70%
1 Year
-37.89%
-37.89%

More News

Read More
Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Levi Strauss Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
ANGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Angion Biomedica Corp. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sumo Logic (Nasdaq – SUMO), Angion Biomedica Corp (Nasdaq - ANGN), TravelCenters of America Inc. (Nasdaq - TA), IAA, Inc. (NYSE - IAA)
From Brodsky & Smith LLC
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
ANGION BIOMEDICA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Angion Biomedica Corp - ANGN
From Kahn Swick & Foti, LLC
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Nasdaq Edges Higher; Neovasc Shares Jump
Via Benzinga
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
Via Benzinga
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Angion Biomedica Corp (Nasdaq - ANGN)
From Brodsky & Smith LLC
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
ANGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Angion Biomedica Corp. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Elicio Therapeutics and Angion Enter into Definitive Merger Agreement
From Angion Biomedica Corp.
Via GlobeNewswire
Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
From Angion Biomedica Corp.
Via GlobeNewswire
Angion Biomedica's Return On Capital Employed Overview
Via Benzinga
Recap: Angion Biomedica Q2 Earnings
Via Benzinga
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
Via Benzinga
Angion Announces Process to Explore Strategic Alternatives for Enhancing and Preserving Shareholder Value
From Angion Biomedica Corp.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.